Bjerner J - Search Results

1

Interference of common haemoglobin variants with the Tosoh G7 standard mode HbA1c method.

Piehler AP, Grimholt RM, Bjerner J, Buchmann MS. Piehler AP, et al. Among authors: bjerner j. Scand J Clin Lab Invest. 2015 Sep;75(5):362-6. doi: 10.3109/00365513.2015.1031687. Epub 2015 Apr 10. Scand J Clin Lab Invest. 2015. PMID: 25858015

2

Discrepancy between HbA1c and fasting glucose results due to HbD.

Piehler AP, Grimholt RM, Bjerner J, Urdal P, Buchmann M. Piehler AP, et al. Among authors: bjerner j. Scand J Clin Lab Invest. 2013 Mar;73(2):186-8. doi: 10.3109/00365513.2012.744089. Epub 2012 Dec 3. Scand J Clin Lab Invest. 2013. PMID: 23198773 No abstract available.

3

Comment on the article entitled "How to deal with dichotomous tests? Application of a Rankit ordinal scale model with examples from the Nordic ordinal scale project on screening tests" by Petersen et al.

Bjerner J. Bjerner J. Scand J Clin Lab Invest. 2009;69(1):28-30. doi: 10.1080/00365510802290681. Scand J Clin Lab Invest. 2009. PMID: 18649166 No abstract available.

4

Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project.

Bjerner J, Biernat D, Fosså SD, Bjøro T. Bjerner J, et al. Scand J Clin Lab Invest. 2009;69(8):873-9.e1-11. doi: 10.3109/00365510903380886. Scand J Clin Lab Invest. 2009. PMID: 19929279

5

Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors.

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N. Nome RV, et al. Among authors: bjerner j. Clin Biochem. 2018 Feb;52:73-79. doi: 10.1016/j.clinbiochem.2017.11.016. Epub 2017 Dec 2. Clin Biochem. 2018. PMID: 29198759 Free article.

6

Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.

Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K. Bjerner J, et al. Scand J Clin Lab Invest. 2008;68(8):703-13. doi: 10.1080/00365510802126836. Scand J Clin Lab Invest. 2008. PMID: 18609108

7

Testing and validating a homogeneous immunometric assay for interference.

Bjerner J, Olsen KH, Børmer OP, Nustad K. Bjerner J, et al. Clin Chem Lab Med. 2004 Feb;42(2):208-14. doi: 10.1515/CCLM.2004.038. Clin Chem Lab Med. 2004. PMID: 15061363

8

Immunometric assay interference: incidence and prevention.

Bjerner J, Nustad K, Norum LF, Olsen KH, Børmer OP. Bjerner J, et al. Clin Chem. 2002;48(4):613-21. Clin Chem. 2002. PMID: 11901059

9

Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera.

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K. Bolstad N, et al. Among authors: bjerner j. Clin Chem Lab Med. 2011 Sep 8;49(12):2001-6. doi: 10.1515/CCLM.2011.702. Clin Chem Lab Med. 2011. PMID: 21899496

10

Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies.

Warren DJ, Bjerner J, Paus E, Børmer OP, Nustad K. Warren DJ, et al. Among authors: bjerner j. Clin Chem. 2005 May;51(5):830-8. doi: 10.1373/clinchem.2004.046979. Epub 2005 Feb 17. Clin Chem. 2005. PMID: 15718486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results